Thalidomide and dexamethasone in patients with multiple myeloma not undergoing upfront autologous stem cell transplantation

Haematologica. 2005 Dec;90(12):1589.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Case Management
  • Case-Control Studies
  • Clinical Trials, Phase II as Topic
  • Dexamethasone / administration & dosage
  • Humans
  • Multiple Myeloma / drug therapy*
  • Peripheral Blood Stem Cell Transplantation
  • Thalidomide / administration & dosage
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Thalidomide
  • Dexamethasone